Skip to main content
FinSpry Logo
FinSpry
ARVN logo
ARVN
(NASDAQ)
Arvinas, Inc.
$7.49-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arvinas (ARVN) Stock Price & Financial Analysis

Arvinas Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.38 - $7.83
52-Week High$14.51
52-Week Low$6.06
Open$7.66
Volume575.60K
Average Volume (3M)934.15K
Market Cap491.94M
Shares Outstanding64.90M
Price to Sales (P/S)1.73
Price to Book (P/B)1.04
EV/EBITDA-2.98
Revenue (TTM)262.60M
Net Income (TTM)-80.80M
Free Cash Flow (TTM)-275.70M
EPS (TTM)$-1.14
Profit Margin-30.77%
Operating Margin-44.02%
Return on Equity (ROE)-18.62%
Debt to Equity0.02
50-Day MA$9.68
200-Day MA$10.67
52-Week Change-7.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arvinas

What is the current stock price for ARVN?

As of the latest trading session, ARVN stock trades at $7.49. The 52-week range is $6.06–$14.51, with a day range of $7.38–$7.83.

What is the P/E ratio for ARVN?

The P/E ratio (Price-to-Earnings) for ARVN is shown in the Key Statistics section. This valuation metric helps compare Arvinas, Inc. to industry peers.

Does ARVN pay dividends?

Arvinas does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARVN?

Based on 4 analysts, the consensus for ARVN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ARVN?

Arvinas's market capitalization is $486.1M, classifying it as a small-cap company. Arvinas operates in the Healthcare sector within the Biotechnology industry.